Empty Capsules Market : Rising Demand For Empty Capsules In The Nutraceutical And Cosmetic Industries

 Major Growth Boosters :

The major factors that are expected to be driving the empty capsules market are the growing adoption of capsule formulations among the growing geriatric population, the growth of the pharmaceutical market with the increasing R&D activities & clinical trial studies, and the advancements in capsule delivery technologies. The objective of the report is to define, describe, and forecast the empty capsules market size based on type, functionality, application, end user, and region.

What This Report Will Provide ?

A softgel consists of a gelatin-based shell surrounding a liquid or semi-solid (inner fill) drug or extract in the center. Softgel capsules offer several benefits to consumers such as convenience, enhanced efficacy, and bioavailability.

Enteric softgel capsules are expected to exhibit significant market growth during the forecast period, owing to rise in adoption of enteric softgel, surge in demand for omega-3 supplements, growth in promotional activities by manufacturers, and rise in consumer awareness for preventative healthcare.

Expected Revenue Growth:

[206 Pages Report] MarketsandMarkets forecasts the Empty Capsules market to grow from USD 1.95 billion in 2018 to USD 2.79 billion by 2023, at a Compound Annual Growth Rate (OTC:CAGR) of 7.4% during the forecast period.

Recent Developments :

• In July 2018, Lonza's Capsule Delivery Solutions launched the Capsugel Vcaps Gen C capsule based on the carrageenan gelling-agent formulation, expanding Lonza’s Capsugel Hydroxypropyl Methyl Cellulose (HPMC) portfolio.
• In February 2018, ACG signed a memorandum of understanding (MOU) with Applied DNA, Inc. (US) that will allow ACG to utilize Applied DNA’s proven SigNature molecular tagging and authentication technologies to develop molecularly tagged empty hard-shell capsules.
• In February 2018, CapsCanada Corporation (Canada) invested USD 28 million in a state-of-the-art manufacturing facility for the production of hydroxypropyl methylcellulose (HPMC) capsules. With this investment, the company expanded its capsule output by 50% to meet the rising global demand for K-CAPS.

Advancement in capsule delivery technologies :

Traditionally, capsules were made from gelatin for manufacturing solid dosage forms for the pharmaceutical industry. Technological advancements have provided the empty capsules industry with a growing range of functionality options for capsules-based formulations used by patients. Over the years, capsule delivery has witnessed a number of technological advancements in terms of product enhancements for better quality outcomes and patient comfort.

Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=218018190

Rising prices and lower availability of raw materials in the gelatin industry

Globally, the demand for gelatin and its raw materials has witnessed a significant increase over the entire application spectrum—the pharmaceutical industry, in which the demand for capsules for pharmaceutical production has registered a vast increase, and the food processing, nutraceuticals, leather, cosmetics, dying & tanning, and paper production industries. All of these also utilize gelatin and raw materials used for its production on a large scale. The use of gelatin in the food preparations has increased six-fold in the last decade.

 

Regional Growth Analysis:

North America is expected to hold the largest market size in the empty capsules market during the forecast period, followed by the European region. The highest market share of North America can be attributed to the existing presence of major capsule manufacturers with large production capacities along with the presence of a number of pharmaceutical giants with large production capacities utilizing these capsules.

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218018190 

Walking Assist Devices Market : North America To Account For The Largest Market Size

 What This Report Will Provide?

This report on the global market is analyzed and segmented on the basis of product, and region. It analyzes the competitive developments, such as alliance, joint venture, and merger & acquisition of the global market. This market is also analyzed with an explicit focus on the high-growth applications and fastest-growing market segments.The walking assist devices are generally used by the patients suffering from spinal cord injuries (SCI), hemiplegia and other types of paralysis, multiple sclerosis (MS), cerebral palsy (CP), amyotrophic lateral sclerosis (ALS), arthritis, and lower-limb amputations.

Expected Revenue Growth:

The global walking assist devices market is expected to reach $6.57 Billion by 2020, at a CAGR of 3.9% from 2015 to 2020.

Major Growth Boosters :

The global market is expected to witness growth in the coming years, owing to factors such as the increase in the number of initiatives undertaken by governments of various countries to ensure availability of walking assist devices to a huge consumer base, rise in aging population, and increasing incidences of Debilitating Neurological Diseases & Injuries.

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=24035174 

Walking Assist Devices Market Stakeholders :

• Companies Manufacturing Walking Assist Devices
• Medical Device Distributors
• Healthcare Institutions (Hospitals, Medical Schools, and Governing Bodies)
• Health Insurance Providers
• Research and Consulting Firms
• Regulatory Authorities

The market is broadly segmented on the basis of product and geography. Based on product, the global market is classified into gaits belts and lift vests, canes, crutches, walkers, wheelchairs, and power scooters. The wheelchairs segment of the global market is the largest and also the fastest growing segment. The rise in geriatric population across the globe and increase in the number of patients suffering from mobility impairment due to spinal cord injuries and paraplegia are some factors leading to growth of the wheelchairs segment of the global market.

Request Sample Report:   https://www.marketsandmarkets.com/requestsampleNew.asp?id=24035174 

The market is broadly segmented on the basis of product and geography. Based on product, the global market is classified into gaits belts and lift vests, canes, crutches, walkers, wheelchairs, and power scooters. The wheelchairs segment of the global market is the largest and also the fastest growing segment. The rise in geriatric population across the globe and increase in the number of patients suffering from mobility impairment due to spinal cord injuries and paraplegia are some factors leading to growth of the wheelchairs segment of the global market.

Regional Growth Analysis:

North America accounted for the largest share in the global walking assist devices market in 2014. The walking assist devices market in the North American region is mostly driven by factors, such as presence of supportive government policies, sophisticated healthcare infrastructure, and increasing geriatric population base. Europe is the fastest growing region in global market in 2014 due to increase in technological advancements in the healthcare sector and development of new products that are equipped with gadgets.

Protein A Resin Market worth USD 1.9 billion : Increasing Demand For Therapeutic Antibodies

 What This Report Will Provide?

The study involved four major activities in estimating the current size for the protein A resin market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size.

Expected Revenue Growth :

[140 Pages Report] The protein A resin market is expected to reach USD 1.9 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 11.4% during the forecast period

Major Growth Boosters :

The growth in this market is mainly driven by the growing demand for disposable pre-packed columns, increasing demand for therapeutic antibodies, and the increasing pharmaceutical R&D spending are expected to drive the growth of this market during the forecast period.However, the high cost of resins is expected to limit the growth of this market.

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19196962 

COVID-19 Impact on the Protein A Resin Market

For the past 30 years, monoclonal antibodies have transformed the way we treat various diseases—they have proven to be more effective, better tolerated, and easier to deliver than other treatments. Researchers are optimistic that monoclonal antibodies could help prevent and treat early infections of COVID-19. Several monoclonal antibodies that are licensed or in development for other diseases are in clinical trials for COVID-19.

Recent Developments

• In 2018, Merck Millipore (Germany) opened a new manufacturing and distribution center in India for its Life Science business.
• In 2017, Repligen Corporation (US) merged with Spectrum Inc. (US), a leader in membrane separation technologies for the pharmaceutical, bioprocess, diagnostic, and research industries. This merger was aimed at accelerating the growth of its filtration business and enhancing its position as a leading developer of single-use and continuous manufacturing technologies for bioprocessing.
• In 2017, Purolite Life Sciences collaborated with ChromaTan Corporation (US), which provides chromatography solutions. The development increased the production of protein A resins by up to 15 times.

Request Sample Report:   https://www.marketsandmarkets.com/requestsampleNew.asp?id=19196962 

The antibody purification segment is expected to command the largest market share e in 2020.

Based on application, the protein A resin market is segmented into antibody purification and immunoprecipitation. In 2020, the antibody purification application segment is expected to command the largest share of the protein A resin market. The large share of this segment can primarily be attributed to the increasing demand for monoclonal antibodies for therapeutic as well as research purposes, which has driven the demand for protein A resins used in the downstream processing of these antibodies.

Regional Growth Analysis:

Geographically, North America is expected to dominate the global the protein A resin market in 2019, while the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high growth in this region can be attributed to the increased R&D activities, as APAC has emerged as a key pharmaceutical and biopharmaceutical research hub. Considering this, a number of key pharmaceutical and biopharmaceutical companies have set up their research centers in the region. Also, local major players such as Ranbaxy, Dr. Reddy’s, Cipla, Lupin, and Cadila are actively involved in research on biosimilars and generic drugs.

Cardiology Information System (CIS) Market : Expand At A Healthy Growth Rate In The Coming Years

 What This Report Will Provide?

The study involved four major activities in estimating the current market size of the China cardiology information system market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Expected Revenue Growth :

[54 Pages Report] The China cardiology information system market is projected to reach $54 million by 2024 from $35 million in 2019, at a CAGR of 8.9% during the forecast period.

Major Growth Boosters :

Growth in this market is mainly driven by the increasing incidence and prevalence of cardiovascular disease, government initiatives in China, and the increasing number of hospitals.

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=264168583

L3A hospitals accounted for the largest share of the China cardiology information system market in 2018

Based on end user, the market is segmented into L3A hospitals and L3B & L2 Hospitals. The L3A hospitals segment accounted for the largest share of the market in 2018. The increasing number of L3A hospitals in China and growing disease prevalence are responsible for the large share of this market segment.

Key Questions Addressed in The Report:

• What are the growth opportunities offered by the market in the next five years?
• How will advancements in products offered by various companies affect the market scenario in the mid- to long-term?
• What are the trends and advancements in the China cardiology information system market?

Request Sample Report :  https://www.marketsandmarkets.com/requestsampleNew.asp?id=264168583

The integrated systems segment is expected to grow at the highest CAGR during the forecast period

Based on system, the market is segmented into integrated and standalone systems. The integrated systems segment is projected to witness the highest growth during the forecast period. The increasing adoption of integrated systems by healthcare providers is the major factor supporting the growth of this segment.

Regional Growth Analysis:Geographically, the biomaterials market is segmented into North America, Europe, Asia Pacific, and Rest of the World. In 2019, North America accounted for the largest share of the biomaterials market, followed by Europe and the Asia Pacific. The large share of North America in the global market is attributed to the increase in biomaterial-based research, rising demand for plastic surgeries, growing incidence of cancer, and the rising prevalence of cardiovascular diseases.

Hemato Oncology Testing Market : Asia Pacific To Register The Highest Growth Rate

 Major Growth Boosters :

Growth in this market is driven by the rising global prevalence of hematologic cancer, growing awareness regarding personalized medicines, and increasing collaborations for developing new assays.

What This Report Will Provide?

The study involved four major activities in estimating the current size of the hemato oncology testing market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research.

Expected Revenue Growth :

[116 Pages Report] The hemato oncology testing market is projected to reach USD 4.0 billion by 2024 from USD 2.0 billion in 2019, at a CAGR of 14.8% during the forecast period.

Download PDF Brochure:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=262472877

Recent Developments:

• In May 2018, Adaptive Biotechnologies (US) collaborated with Sanofi, SA. (US), to utilize Adaptive’s clonoSEQ Assay to measure MRD status in response to isatuximab
• In July 2018, Abbott Laboratories (US) received FDA approval for its Abbott RealTime IDH1 kit
• In May 2018, Invivoscribe, Inc. (US) partnered with the American University of Beirut Medical Center (AUBMC) (Lebanon) to create a new center of excellence facility in the Middle East

Key Questions Addressed in The Report:

• What are the growth opportunities in the hemato oncology testing across major regions in the future?
• Emerging countries have immense opportunities for the growth and adoption of hemato oncology testing. Will this scenario continue during the next five years?
• What are the new trends and advancements in the hemato oncology testing?
• What initiatives are being undertaken by market players?
• Which of the segments will drive the market growth in the future?

Request Sample Report :   https://www.marketsandmarkets.com/requestsampleNew.asp?id=262472877

Based on product & services, the hemato oncology testing is segmented into services and assay kits. In 2018, the services segment accounted for the largest share of the hemato oncology testing. This is mainly due to the increasing prevalence & incidence of leukemia, non-Hodgkin lymphoma, and myeloma cancers. Apart from this, rising awareness regarding advanced treatment therapies such as personalized medicine is also driving the growth of this segment.

Regional Growth Analysis:

Based on region, the hemato oncology testing is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW). While North America dominated the market in 2018, Asia Pacific is expected to register the highest CAGR in the market during the forecast period. Growth in the APAC market is driven mainly by the large patient population, and increasing focus of major players on expanding in this region will drive market growth.

Autoinjector Market Worth USD 104.9 Billion : Growing Prevalence Of Targeted Therapies And Technological Advancements

 Expected Revenue Growth:

[180 Pages Report] The global autoinjectors market is projected to reach USD 104.9 billion by 2025 from USD 46.0 billion in 2020, at a CAGR of 17.9% from 2020 to 2025.

What This Report Will Provide?

This study involved four major activities in estimating the current autoinjectors market size. Exhaustive research was conducted to collect information on the market as well as its peer and parent markets.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the number of breast lesion localization procedures and the value market.

Major Growth Boosters:

Market growth is largely driven by the growing prevalence of targeted therapies, the rising incidence of anaphylaxis, rising preference for self-administration of drugs, usability advantages, the increasing number of regulatory approvals, the availability of generic versions of autoinjectors, favorable reimbursements and government support, and technological advancements.

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173991724  

COVID-19 Impact on The Autoinjectors :

The COVID-19 pandemic has resulted in a global healthcare crisis, causing a shift in healthcare delivery in most regions. Most non-essential procedures and in-hospital therapies were deferred in the first half of 2020 to prevent the spread of the infection and ease the toll on healthcare infrastructure.

Recent Developments :

• In August 2020, Antares Pharma (US) signed an agreement with Lunatus Global Medical Supplies (Dubai). In this agreement, Antares will supply packaged products to Lunatus and Lunatus will submit and obtain regulatory approval for XYOSTED in the UAE and Saudi Arabia as well as promote, market, and distribute XYOSTED in these two countries.
• In March 2020, SHL Medical (Switzerland) acquired Weibel CDS (Switzerland). This acquisition aimed at strengthening SHL Medical’s ability to provide more advanced drug delivery systems based on human-centered designs and functionality.
• In January 2020, Eli Lilly invested USD 470 million and created over 460 new jobs in Durham, NC. This expansion brought a new state-of-the-art pharmaceutical manufacturing facility to North Carolina’s research triangle park.

Frequently Asked Questions (FAQ):

• Which are the top industry players in the global autoinjectors market?
• What are the top trends in the autoinjectors market?
• Which autoinjectors market, by therapy, have been included in this report?
• Which geographical region is dominating in the autoinjectors market?
• Which is the leading therapy in the autoinjectors market?

Request Sample Report:   https://www.marketsandmarkets.com/requestsampleNew.asp?id=173991724  

Need to limit patient visits and physical contact :

The current COVID-19 pandemic has resulted in the implementation of a fresh set of protocols that aim to reduce patient visits to hospitals and clinics in non-emergency conditions to prevent both the transmission of the virus as much as make sure healthcare institutions are not overwhelmed. In this situation, the preference for home-use autoinjectors has risen among patients suffering from chronic illnesses and allergies. This also protects vulnerable high-risk populations from exposure to the virus during hospital visits.

Regional Growth Analysis:

Geographically, the autoinjectors market is segmented into North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. Growth in the Asia Pacific market is majorly driven by the large diabetes population and increasing healthcare expenditure which has drawn a number of major autoinjector device manufacturers to this region. These companies are increasing their presence in the Asia Pacific market through several approaches, such as establishing sales offices and partnering with local pharmaceutical companies.

Transfer Membrane Market Worth USD 187.9 : Current Status, Statistics, Growth Dynamics And Future Trends

 What This Report Will Provide?

This research study involved the usage of extensive secondary sources, directories, and databases such as D&B, Bloomberg Business, and Factiva, along with government databases, to identify and collect information useful for this technology-based, market-oriented, and commercial study of the transfer membrane market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as to assess future prospects.

Expected Revenue Growth:

[124 Pages Report] The transfer membrane market is projected to reach USD 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5% during the forecast period.

Major Growth Boosters:

Factors such as increasing public and private funding for life science research, the significantly high prevalence of target diseases across the globe, and increasing R&D spending by pharmaceutical and biotechnology companies are expected to drive the growth of market.

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36975865 

Objectives of the study are:

• To define, describe, and forecast the market by type, transfer method, application, end user, and region
• To provide detailed information regarding the major factors influencing market growth (drivers, restraints, and opportunities) along with the current trends
• To strategically analyze micromarkets with respect to their individual growth trends, prospects, and contributions to the total market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
• To forecast the revenue of the market segments in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa

Based on end user, the market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and other end users. Among these, the academic and research institutes segment is expected to account for the largest share of the transfer membrane market in 2018, owing it to the rising financial support from private as well as government bodies for life science research in various nations.

Request Sample Report:   https://www.marketsandmarkets.com/requestsampleNew.asp?id=36975865 

On the basis of type, the market is divided into nylon membranes, nitrocellulose membranes, and PVDF membranes. In 2018, PVDF Membranes are expected to command for the major share of the market. This can be attributed to the advantages of PVDF membranes over its counterparts, such as better protein retention, strength, chemical compatibility, and wide applications in western blotting.

Regional Growth Analysis:

North America is expected to account for the largest share of the global transfer membrane market in 2018, followed by Europe. The large share in the North American region is mainly attributed to the presence of leading transfer membrane manufacturers in the region, availability of government and private financial support for life science research, and high target disease prevalence in the region.